{
    "2020-06-14": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Sanofi Leads Second Tier of R&D Spenders",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "R&D",
                        "spenders"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie, Rocheâ€™s AML Therapy Shows Significant Survival Benefits",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Roche",
                        "AML",
                        "therapy",
                        "survival",
                        "benefits"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}